bladder cancer
Diatech, Janssen Partner to Develop Molecular Diagnostics for Bladder Cancer
The bladder cancer test in development will profile genetic alterations in bladder cancer in three hours using real-time PCR.
New Bladder Cancer Molecular Classification Predicts Response to Common Immunotherapy
The new subtypes could help clinicians pick alternative therapies for patients unlikely to respond to Bacillus Calmette-Guérin treatment.
Convergent Genomics Building Data on Urine-Based Assay to Diagnose, Monitor Urothelial Carcinoma
Premium
The Oregon Health and Science University spinout also recently presented data suggesting the test could help predict future urothelial carcinoma.
GeneCentric Begins Study to Validate RNA Gene Signature Test in Bladder Cancer
GeneCentric investigators will assess the ability of the FGFR predictive response signature to identify bladder cancer patients who may benefit from targeted therapy.
Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test
Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types.